Hand-Foot Syndrome: Prevention and Strategies

Hand-Foot Syndrome (Palmar-Plantar Erythrodysesthesia): Prevention and Management During Cancer Treatment

Hand-Foot Syndrome (Palmar-Plantar Erythrodysesthesia): Prevention and Management During Cancer Treatment. Learn what hand-foot syndrome is, how to identify it, prevention strategies, and when to notify your doctor

Key Takeaways-

Hand-foot syndrome (HFS), also called palmar-plantar erythrodysesthesia, is a common side effect of several chemotherapy drugs, especially capecitabine (Xeloda), 5-fluorouracil (5-FU), pegylated liposomal doxorubicin (Doxil), and some targeted therapies.
Early recognition is critical. Mild symptoms can often be controlled before they become severe enough to require chemotherapy dose reductions.
Evidence supports regular use of urea-containing moisturizers, friction reduction, temperature management, and prompt communication with your oncology team.
Several medications—including celecoxib and more recently topical diclofenac—have shown promise in clinical trials for prevention in selected patients, but they should only be used under physician supervision.

I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.

Scroll down the page and post a question or a comment if there’s anything you’d like to know about hand and foot syndrome.

Good luck,

David Emerson

What is hand-foot syndrome?

What Is Hand-Foot Syndrome?

Hand-foot syndrome is a skin reaction caused by certain chemotherapy and targeted cancer drugs. The palms of the hands and soles of the feet become inflamed because small amounts of chemotherapy leak into tiny blood vessels in these areas.

Although HFS is rarely life-threatening, it can become one of the most disabling side effects of cancer treatment, making it difficult to:

Walk
Button clothing
Cook
Type
Exercise
Sleep comfortably

For some patients, severe HFS forces chemotherapy delays or dose reductions that may affect treatment intensity.

Which Cancer Treatments Cause Hand-Foot Syndrome?

Common chemotherapy drugs include:

Capecitabine (Xeloda)
Continuous infusion 5-FU
Pegylated liposomal doxorubicin (Doxil)
Cytarabine (high-dose)
Docetaxel (occasionally)

Targeted therapies associated with similar symptoms include:

Sorafenib
Sunitinib
Regorafenib
Cabozantinib
Lenvatinib

The skin reaction from targeted therapies is technically called Hand-Foot Skin Reaction (HFSR) and differs somewhat from classic chemotherapy-induced HFS.

Symptoms

Early symptoms include:

Tingling
Numbness
Burning sensation
Tight skin
Increased sensitivity

As symptoms worsen:

Redness
Swelling
Dryness
Peeling
Cracked skin
Blisters
Severe pain

Grade 3 HFS may make walking or using your hands extremely difficult.

Risk Factors

You may have a higher risk if you:

Receive higher cumulative chemotherapy doses
Take capecitabine continuously
Already have dry skin
Have diabetes
Have poor circulation
Perform repetitive manual labor
Walk long distances during treatment

Prevention Strategies

1. Moisturize Before Symptoms Begin ⭐⭐⭐⭐☆

The strongest evidence supports frequent moisturizing.

Many cancer centers recommend creams containing:

10–20% urea
Lanolin
Ceramides
Petrolatum

Apply:

Morning
Evening
After bathing
Before bed

Several randomized trials have evaluated urea creams for prevention, although the magnitude of benefit varies.

2. Reduce Friction ⭐⭐⭐⭐⭐

During treatment:

Avoid:

Tight shoes
High heels
Long walks
Running
Heavy yard work
Repetitive gripping
Weight lifting without gloves

Instead:

Wear cushioned shoes
Use padded socks
Wear comfortable gloves when doing chores

3. Keep Hands and Feet Cool ⭐⭐⭐⭐☆

Heat increases blood flow, potentially exposing skin to more chemotherapy.

Helpful ideas:

Lukewarm showers
Cooling packs (never directly on skin)
Avoid hot tubs
Avoid prolonged sun exposure

Some infusion centers also use cooling gloves and socks during chemotherapy.

4. Treat Dry Skin Immediately ⭐⭐⭐⭐⭐

Tiny cracks quickly become painful.

Use moisturizer several times daily.

Avoid:

Alcohol-based lotions
Harsh soaps
Excessive hand sanitizer

5. Report Symptoms Early ⭐⭐⭐⭐⭐

Many patients wait until symptoms become severe.

Instead, tell your oncology team immediately if you notice:

Tingling
Redness
Tenderness
Peeling

Early intervention often prevents progression.

Conventional Treatments

Depending on severity, your oncologist may recommend:

Topical corticosteroids

Reduce inflammation.

Pain medications

Including:

Acetaminophen
NSAIDs (if appropriate)
Prescription pain medication

Dose modification

The single most effective treatment for severe HFS is often:

Temporary treatment interruption
Dose reduction
Longer interval between cycles

This allows damaged skin to heal.

Integrative Therapies With Evidence

Urea Cream ⭐⭐⭐⭐☆

Most commonly recommended supportive therapy.

Celecoxib ⭐⭐⭐☆☆

Several meta-analyses found celecoxib reduced the incidence of moderate-to-severe HFS, but because it carries cardiovascular and gastrointestinal risks, it should only be used after discussion with your oncologist.

Topical Diclofenac ⭐⭐⭐⭐☆

A 2026 network meta-analysis found topical diclofenac produced one of the largest reductions in moderate-to-severe HFS and reduced chemotherapy modifications, though more clinical experience is still accumulating.

Pyridoxine (Vitamin B6) ⭐⭐☆☆☆

Despite years of use, evidence remains inconsistent.

Routine use is not universally recommended.

Gentle Exercise ⭐⭐⭐☆☆

Maintaining circulation is beneficial, but avoid activities that increase pressure on painful skin.

Good choices:

Easy walking
Stationary cycling
Swimming (if skin is intact)

Nutrition

Although no specific diet prevents HFS, overall skin health benefits from:

Adequate protein
Omega-3 fats
Fruits
Vegetables
Good hydration

Patients who become dehydrated often notice worsening symptoms.

When Should You Call Your Doctor?

Contact your oncology team if you develop:

Severe pain
Difficulty walking
Blisters
Open sores
Bleeding
Fever
Signs of infection
Inability to perform daily activities

Never assume severe HFS is “just part of chemotherapy.”

Evidence-Based Prevention Checklist

Strategy	Evidence
Daily moisturizing	⭐⭐⭐⭐☆
Urea cream	⭐⭐⭐⭐☆
Reduce friction	⭐⭐⭐⭐⭐
Cooling hands/feet	⭐⭐⭐⭐☆
Early symptom reporting	⭐⭐⭐⭐⭐
Dose modification	⭐⭐⭐⭐⭐
Celecoxib (selected patients)	⭐⭐⭐☆☆
Topical diclofenac (emerging evidence)	⭐⭐⭐⭐☆
Pyridoxine	⭐⭐☆☆☆

How I Evaluate Hand-Foot Syndrome Therapies

Therapy	Quality of Evidence	Magnitude of Benefit	Safety	Overall PeopleBeatingCancer Rating
Dose modification when needed	High	High	High	⭐⭐⭐⭐⭐
Urea cream	Moderate-High	Moderate	Excellent	⭐⭐⭐⭐☆
Friction reduction	Moderate	Moderate	Excellent	⭐⭐⭐⭐⭐
Cooling strategies	Moderate	Moderate	Excellent	⭐⭐⭐⭐☆
Celecoxib	Moderate	Moderate	Use selectively	⭐⭐⭐☆☆
Topical diclofenac	Moderate (new evidence)	Moderate-High	Good	⭐⭐⭐⭐☆
Vitamin B6	Low-Moderate	Small/Inconsistent	Good	⭐⭐☆☆☆

Research

Reviews

Management of cytotoxic chemotherapy-induced hand-foot syndrome (2020)
Chemotherapy-induced hand-foot syndrome and nail changes (2014)
Hand-foot syndrome associated with cancer therapy (review)

Meta-analyses

Preventing Hand-Foot Syndrome in Patients With Cancer (JAMA Dermatology, 2026)
Hand-foot syndrome prevention: pharmacological interventions (BMJ Supportive & Palliative Care, 2026)
Comparative efficacy and safety of prophylactic therapies (2022)

Our Mission